Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and ...
With the $27.5-million Dulles Tier 2/Concourse C APM Station - Concourse C Connector project, the new $2 billion automated people mover system at Dulles International Airport in Chantilly, Va., is ...
Biopharmaceutical company Aptorum Group Ltd. (NASDAQ:APM) saw its pre-market stock price on Tuesday jump by nearly 300 percent, with investor optimism fueled by the company’s improved earnings ...